Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea

  • Dong W. Kim
  • , Yousun Lee
  • , Geuntae Kim
  • , Sang H. Kim
  • , Dae H. Cho
  • , Jeongmin Choi
  • , Yong H. Kwon
  • , Younjin Park
  • , Wooree Choi
  • , Dong I. Park

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science